Celleron Therapeutics Ltd.

https://www.cellerontherapeutics.com

Celleron is an oncology company focussed on the clinical development of new and innovative therapies to treat cancer. Celleron is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. The company's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company has deep relationships with Oxford University and is located on the Oxford Science Park, United Kingdom. *

	Start	2020-11-19 existent
	Industry	cancer drug
	Industry 2	drug development
	Person	Fleming, Bill (Oxitec 201704 CFO joined 2010 before Bayer + OBN 201704– Board Member)

	Region	Oxford, Oxfordshire
	Country	United Kingdom (GB)
	City	n. a. Oxford, Oxfordshire
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: SynOx Therapeutics Ltd.. (11/19/20). "Press Release: SynOx Therapeutics Raises €37M in Series A Financing. HealthCap and Medicxi Co-lead, Joined by Forbion and Gimv". Dublin.

		Record changed: 2025-03-16

Picture EBD Group Asia Bio Partnering Forum 2026 Singapore 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]